Thrombotic complications are frequent in COVID‐19 and contribute significantly to mortality
and morbidity. We review several mechanisms of hypercoagulability in sepsis that may be …

The world is amid a pandemic caused by severe acute respiratory syndrome-coronavirus 2.
Severe acute respiratory syndrome-coronavirus causes serious respiratory tract infections …

The Covid-19 pandemic has introduced an array of organspecific and systemic phenotypes-
some previously observed in viral infections, including severe acute respiratory syndrome …

Objective: Pulmonary thrombosis is observed in severe acute respiratory syndrome
coronavirus 2 pneumonia. Aim was to investigate whether subpopulations of platelets were …

The emergence of Coronavirus Disease 19 (COVID-19) as a pandemic has claimed
hundreds of thousands of lives worldwide since its initial breakout. With increasing reports …

Introduction Comprehensive studies investigating sustained hypercoagulability, endothelial
function, and/or inflammation in relation to post-COVID-19 (PCC) symptoms with a …

Since the initial description in 2019, the novel coronavirus SARS-Cov-2 infection (COVID-
19) pandemic has swept the globe. The most severe form of the disease presents with fever …

To systematically analyze the blood coagulation features of coronavirus disease 2019
(COVID‐19) patients to provide a reference for clinical practice. An electronic search in …

Evidence of micro-and macro-thrombi in the arteries and veins of critically ill COVID-19
patients and in autopsies highlight the occurrence of COVID-19-associated coagulopathy …

Background: Blood coagulation disorders commonly occur with severe coronavirus disease
2019 (COVID-19). However, there is only limited evidence on differentiating the pattern of …